GlassScriptPhysician profile
Robert W Beaumont
NPI 1740662915
$1,887.26
in general payments reported to CMS, 2019-2025
17 companies · $27.21 in 2025
The $27.21 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $151 · 2023: $873 · 2024: $836 · 2025: $27.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,736.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $528.51 | 2022-2025 | |
| Amgen INC. | $360.04 | 2023-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $161.72 | 2022-2024 | Farxiga, Brilinta |
| Pfizer INC. | $134.55 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.76 | 2023-2024 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $117.66 | 2023-2024 | Inpefa |
| Merck Sharp & Dohme LLC | $113.70 | 2022-2024 | Verquvo |
| Kiniksa Pharmaceuticals International, Plc | $90.13 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $52.90 | 2024 | Zio Monitor, Zio Xt Patch |
| Janssen Pharmaceuticals, INC | $43.29 | 2023-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.24 | 2023 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $24.21 | 2024 | |
| Abbott Laboratories | $23.59 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $21.18 | 2023 | Arcalyst |
| Esperion Therapeutics, INC. | $16.92 | 2024 | Nexletol |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16.53 | 2023 | Micra |
| Scpharmaceuticals INC. | $16.33 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Beaumont listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.